
Global Markets for Drug-Device Combinations
Description
Global Markets for Drug-Device Combinations
Report Scope:
The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations’ current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.
Report Includes:
40 data tables and 43 additional tables
Overview of the global markets for drug-device combination (DDC) products and biological devices
Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region
Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors
Review of the industry supply chain, using the Porter’s Five Forces model, to analyze the microand macro environmental factors prevailing in the marketplace
Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
An analysis of the industry structure, including companies’ market shares, alliances, M&A activity and venture funding outlook
Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD
Companies Mentioned
3M
ABBOTT
B. BRAUN SE
BD
BOSTON SCIENTIFIC CORP.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
SMITH+NEPHEW
STRYKER
TERUMO CORP.
Table of Contents
115 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Market Insights
- Regulatory Landscape
- Patent Review
- Product Recalls
- Product Pipeline
- Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Drivers
- Wide Range of Potential Applications of Combinations Products
- Growing Prevalence of Chronic Diseases
- Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
- Restraints
- Device Reliability and Robustness
- Human Factors Testing
- Drug and Device Integration
- Accommodating Different Volumes
- Challenges
- Biological Safety Challenges in Drug-Device Combinations
- Regulatory Challenges
- Opportunities
- Technology advancements and Innovative Product Launches
- Continuous Growth
- Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market
- Chapter 4 Market Segmentation Analysis
- Segmentation Breakdown
- Drug-Device Combinations Market by Product Type
- Drug/Biologic-Device Combination Products
- Drug-Biologic Drug-Device Combination Products
- Drug, Device and Biologic Combination Products
- Drug-Device Combinations Market by Application
- Cardiovascular Diseases
- Metabolic Disorders
- Respiratory Diseases
- Wound Care
- Oncology
- Orthopedic Conditions
- Others
- Geographic Breakdown
- Drug-Device Combinations Market, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 5 Emerging Trends and Technologies
- Overview
- AI in Drug-Device Combination
- Nanotechnology
- Computational Models and Simulation
- Human Organs-on-Chips: Revolutionizing Medical Research
- Implantable Drug Delivery Systems
- Wireless Implants
- Smart Drug Delivery Devices for 3D Printing
- Recent Approvals and Launch of Novel Drug-device Combination Products
- Chapter 6 ESG Development
- Introduction
- ESG Sustainability in Drug-Device Combinations Market
- ESG Risk Ratings
- WHO Guidelines and Global Initiatives
- BCC Research Viewpoint
- Chapter 7 Competitive Landscape
- Company Share Analysis
- Mergers, Acquisitions and Collaborations
- Strategic Alliances
- Chapter 8 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- 3M
- ABBOTT
- B. BRAUN SE
- BD
- BOSTON SCIENTIFIC CORP.
- JOHNSON & JOHNSON SERVICES INC.
- MEDTRONIC
- SMITH+NEPHEW
- STRYKER
- TERUMO CORP.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.